CompoAtlas

Lip Clear Lysine+

Natural health product licensed in Canada

Other names
Super Lysine+
Licence holder
QH Holdings (Oregon), dba Quantum Inc., and Quantum Health
NPN or DIN-HM
80071574
Status
Active licence
Licence date
2 August 2016
Revision date
Not provided
Form
Onguent
Route of administration
Topique
Application type
Non traditionnelle

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
L-Lysine

Source : Monochlorhydrate de L-lysine

1.28 %
Olea europaea

Source : Chair (fruit)

78 %
Oxyde de zinc

Source : Oxyde de zinc

0.99 %

Non-medicinal ingredients

Cholécalciférol, Poudre d'Hydrastis canadensis (Hydraste du Canada), Extrait floral de Calendula Officinalis, Menthol, Résine de benjoin, Extrait d'Echinacea purpurea, Extrait de cire de propolis, Miel, Palmitate de rétinyle, Cire d'abeille, Mélange de concentré de tocophérols, Huile essentielle d'arbre à thé, Huile essentielle de feuilles de Melaleuca Leucadendron Cajuputi

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years ; maximum: 65 years1 Onguentminimum: 1 Tous les jours ; maximum: 10 Tous les jours

Uses authorised in Canada

For the relief of cold sores.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80071574

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line